Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-17-022460
Filing Date
2017-04-27
Accepted
2017-04-27 09:41:25
Documents
1
Period of Report
2017-04-27

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v465358_6k.htm 6-K 16897
  Complete submission text file 0001144204-17-022460.txt   17903
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 17786571
SIC: 2834 Pharmaceutical Preparations